Acrivon Therapeutics Ownership | Who Owns Acrivon Therapeutics?

Acrivon Therapeutics Ownership Summary

Acrivon Therapeutics is owned by 46.27% institutional investors, 20.71% insiders, and 33.02% retail investors. Ra capital management is the largest institutional shareholder, holding 21.69% of ACRV shares. HBM Healthcare Investments AG Ord is the top mutual fund, with 1.68% of its assets in Acrivon Therapeutics shares.

ACRV Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Acrivon Therapeutics	46.27%	20.71%	33.02%
Sector	Healthcare Stocks	488.30%	11.08%	-399.38%
Industry	Biotech Stocks	307.10%	11.11%	-218.21%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Ra capital management	8.34M	21.69%	$9.93M
Sands capital ventures	2.12M	5.52%	$2.53M
Blackrock funding, inc. /de	407.62K	1.06%	$485.07K
Marshall wace, llp	181.19K	0.47%	$215.61K
Hrt financial lp	145.90K	0.38%	$173.00K
Xtx topco	106.12K	0.28%	$126.28K
Baker bros. advisors lp	22.81K	0.06%	$27.14K
Quadrature capital	22.18K	0.06%	$26.28K
Qube research	12.69K	0.03%	$15.10K
Mirae asset global investments	1.21K	0.00%	$1.44K

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Sands capital ventures	2.12M	0.50%	$2.53M
Ra capital management	8.34M	0.17%	$9.93M
Xtx topco	106.12K	0.01%	$126.28K
Hrt financial lp	145.90K	0.00%	$173.00K
Quadrature capital	22.18K	0.00%	$26.28K
Baker bros. advisors lp	22.81K	0.00%	$27.14K
Marshall wace, llp	181.19K	0.00%	$215.61K
Dafna capital management	-	-	-
New york state common retirement fund	-	-	-
Prelude capital management	-	-	-

Top Buyers

Holder	Shares	% Assets	Change
Hrt financial lp	145.90K	0.00%	145.90K
Xtx topco	106.12K	0.01%	106.12K
Quadrature capital	22.18K	0.00%	22.18K
Qube research	12.69K	-	12.69K
Mirae asset global investments	1.21K	-	169.00

Top Sellers

Holder	Shares	% Assets	Change
Perceptive advisors	-	-	-5.36M
Blackrock funding, inc. /de	407.62K	-	-531.09K
Marshall wace, llp	181.19K	0.00%	-269.20K
Dafna capital management	-	-	-112.41K
Invesco	-	-	-35.31K

New Positions

Holder	Shares	% Assets	Change	Value
Hrt financial lp	145.90K	0.00%	145.90K	$173.00K
Xtx topco	106.12K	0.01%	106.12K	$126.28K
Quadrature capital	22.18K	0.00%	22.18K	$26.28K
Qube research	12.69K	-	12.69K	$15.10K

Sold Out

Holder	Change
Sterling capital management	-198.00
Russell investments group	-223.00
Gamma investing	-287.00
Amalgamated bank	-378.00
Deutsche bank ag\	-541.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Jun 30, 2025	51	-15.00%	17,796,335	-20.97%	46	1.34%	25	4.17%	16	-23.81%
Mar 31, 2025	4	-93.10%	14,129,412	-38.60%	36	1.01%	-	-100.00%	1	-92.86%
Dec 31, 2024	59	15.69%	23,249,551	1.26%	61	1.68%	31	29.17%	14	-
Sep 30, 2024	51	-	22,960,755	-2.09%	60	1.43%	24	-31.43%	14	133.33%
Jun 30, 2024	51	10.87%	23,451,878	53.83%	64	1.43%	35	45.83%	6	-33.33%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
HBM Healthcare Investments AG Ord	527.15K	1.68%	-39.51K
Vanguard Total Stock Mkt Idx Inv	403.61K	1.28%	-8.82K
Vanguard US Total Market Shares ETF	387.41K	1.24%	-
Fidelity Small Cap Index	129.48K	0.41%	-
iShares Biotechnology ETF	125.85K	0.40%	-
Vanguard Institutional Extnd Mkt Idx Tr	121.16K	0.39%	-55.21K
iShares Russell 2000 Value ETF	108.94K	0.35%	-
A4Investments SICAV SIF ACCI IlanaA2EURH	84.78K	0.27%	30.72K
Fidelity Extended Market Index	73.47K	0.23%	-605.00
State St Russell Sm/Mid Cp® Indx NL Cl C	64.10K	0.20%	-

Recent Insider Transactions

Date	Name	Role	Activity	Value
May 01, 2025	PERCEPTIVE ADVISORS LLC	-	Sell	$400.51K
Apr 30, 2025	PERCEPTIVE ADVISORS LLC	-	Sell	$617.41K
Apr 29, 2025	PERCEPTIVE ADVISORS LLC	-	Sell	$352.50K
Apr 25, 2025	PERCEPTIVE ADVISORS LLC	-	Sell	$2.06M
Apr 28, 2025	PERCEPTIVE ADVISORS LLC	-	Sell	$335.84K

Insider Transactions Trends

Date	Buy	Sell
2025 Q4	-	-
2025 Q3	-	-
2025 Q2	-	5
2025 Q1	-	-
2024 Q4	-	-

ACRV Ownership FAQ

Who Owns Acrivon Therapeutics?

Acrivon Therapeutics shareholders are primarily institutional investors at 46.27%, followed by 20.71% insiders and 33.02% retail investors. The average institutional ownership in Acrivon Therapeutics's industry, Biotech Stocks , is 307.10%, which Acrivon Therapeutics falls below.

Who owns the most shares of Acrivon Therapeutics?

Acrivon Therapeutics’s largest shareholders are Ra capital management (8.34M shares, 21.69%), Sands capital ventures (2.12M shares, 5.52%), and Blackrock funding, inc. /de (407.62K shares, 1.06%). Together, they hold 28.26% of Acrivon Therapeutics’s total shares outstanding.

Does Blackrock own Acrivon Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Acrivon Therapeutics.

Who is Acrivon Therapeutics’s biggest shareholder by percentage of total assets invested?

Sands capital ventures is Acrivon Therapeutics’s biggest shareholder by percentage of total assets invested, with 0.50% of its assets in 2.12M Acrivon Therapeutics shares, valued at 2.53M$.

Who is the top mutual fund holder of Acrivon Therapeutics shares?

HBM Healthcare Investments AG Ord is the top mutual fund holder of Acrivon Therapeutics shares, with 1.68% of its total shares outstanding invested in 527.15K Acrivon Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools